Funding Opportunity RFA-MH-18-701 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) seeks to support clinical trials to establish the effectiveness of interventions and to test hypotheses regarding moderators, mediators, and mechanisms of action of these interventions. This FOA supports clinical trials designed to test the therapeutic value of treatment and preventive interventions for which there is already evidence of efficacy, for use in community and practice settings. Applications might include research to evaluate the effectiveness or increase the clinical impact of pharmacologic, somatic, psychosocial (psychotherapeutic, behavioral), device-based, rehabilitative and combination interventions to prevent or treat mental illness. This FOA also supports clinical trials to test patient-, provider-, organizational-, or systems-level services interventions to improve access, continuity, quality, equity, and/or value of services. The intervention research covered under this announcement is explicitly focused on practice-relevant questions.

Funding Opportunity RFA-MH-18-700 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) seeks to support clinical trials to establish the effectiveness of interventions and to test hypotheses regarding moderators, mediators, and mechanisms of action of these interventions. This FOA supports clinical trials designed to test the therapeutic value of treatment and preventive interventions for which there is already evidence of efficacy, for use in community and practice settings. Applications might include research to evaluate the effectiveness or increase the clinical impact of pharmacologic, somatic, psychosocial (psychotherapeutic, behavioral), device-based, rehabilitative and combination interventions to prevent or treat mental illness. This FOA also supports clinical trials to test patient-, provider-, organizational-, or systems-level services interventions to improve access, continuity, quality, equity, and/or value of services. The intervention research covered under this announcement is explicitly focused on practice-relevant questions.

The Computational Biology Institute seeks faculty members to establish externally funded, internationally recognized, and interdisciplinary research programs in...
From George Washington University - Tue, 14 Nov 2017 11:49:22 GMT - View all United States jobs

Good communication skills – Should be fluent in English and Knowing Hindi is preferred. Masters in life science – Biotechnology/Biochemistry/Bioinformatics...
From Nielsen - Tue, 14 Nov 2017 11:37:49 GMT - View all Indiana jobs

Competitive Salary: EMBL: Bioinformatician/Information scientistLocation:EMBL-EBI Hinxton near Cambridge, UK Staff Category:Staff MemberContract Duration:until 30th November 2020Grading:5 (monthly salary starting at £2,552 after tax). For more information about pay and benefits c Hinxton, Cambridgeshire, England

Celgene: Other Locations:US- WA- Seattle; US- MA- Cambridge; US- CA- San Diego; US- CA- San Francisco- Emeryville; US- NJ- Summit WestDescriptionCelgene is a global biopharmaceutical company leading the way in medical innovation to help patients live longer, bette Cambridge, Cambridgeshire, England

A Four-year university degree required in Bachelor of Science, Nursing or related healthcare field preferred....
From Natera - Mon, 13 Nov 2017 20:42:03 GMT - View all Remote jobs

Attractive stipend and fringe benefits: UT Health San Antonio: UT Health San Antonio seeks 2 postdoctoral fellows with experience in applying bioinformatics tools for cancer and stem cell research. San Antonio, Texas

Negotiable: Paramount Recruitment: Software Engineer - NGS London A great opportunity is available for a scientific software developer to join a highly talented team based in London who are integrating cutting-edge semiconductor technologies with novel biochemical techniques to develop a London, England

Funding Opportunity PAR-18-346 from the NIH Guide for Grants and Contracts. The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The over-arching goal of this National Insitute of Neurological Disorders and Stroke R25 program is to support educational activities that complement and/or enhance the training of a workforce to meet the nations biomedical, behavioral and clinical research needs. To accomplish the stated over-arching goal, this FOA will support creative educational activities with a primary focus on research experiences, designed to foster the development of physicians as research scientists in areas relevant to the NINDS mission. The research experiences will prepare clinicians to successfully compete for individual NIH mentored career development awards, or where appropriate, independent research awards. This FOA will also support educational activities such that participants of the R25 are expected to attend and participate in an annual workshop specific to this FOA to present their work, discuss progress and plans towards transitioning to the next career stage and to network with other researchers and leaders in their fields. Such success will facilitate their transition from resident/fellow to physician-scientist, and will thus foster retention of a cadre of physician-scientists who will conduct research into the mechanisms of, etiology, and treatment of neurological diseases.

Funding Opportunity PA-18-286 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to encourage submission of Exploratory/Developmental Bioengineering Research Grants (EBRG) applications which establish the feasibility of technologies, techniques or methods that: 1) explore a new multidisciplinary approach to a biomedical challenge; 2) are high-risk but have high impact; and 3) develop data that may lead to significant future research. An EBRG application may propose hypothesis-driven, discovery-driven, developmental, or design-directed research and is appropriate for evaluating unproven approaches for which there is minimal or no preliminary data.

Experience dependent: Hyper Recruitment Solutions (HRS): We are currently looking for a Bioinformatics Developer to join a leading company with offices based in Manchester and Belfast, Northern Ireland. They are a... Manchester

Funding Opportunity RFA-AG-18-023 from the NIH Guide for Grants and Contracts. NeuroHIV is at an inflection point, with an urgent need to understand the mechanisms that cause and modulate the CNS impairment in the era of antiretroviral therapies.

Notice NOT-HD-17-024 from the NIH Guide for Grants and Contracts

Funding Opportunity PA-18-334 from the NIH Guide for Grants and Contracts. The NIDCD is committed to identifying effective interventions for the diagnosis, prevention, or treatment of communication disorders by supporting welldesigned and wellexecuted clinical trials. This funding opportunity announcement (FOA) supports investigator initiated low risk clinical trials addressing the mission and research interests of NIDCD. Clinical trials must meet ALL the following criteria: meet the budget limits of this FOA, not require FDA oversight, are not intended to formally establish efficacy and have low risks to potentially cause physical or psychological harm. It is advisable that only one clinical trial be proposed in each NIDCD Clinical Trials in Communication Disorders R01 application. High risk clinical trials not meeting all the criteria above are referred companion U01 FOA PAR-18-340, NIDCD Cooperative Agreement for Clinical Trials in Communication Disorders.

Funding Opportunity PAR-18-340 from the NIH Guide for Grants and Contracts. The NIDCD is committed to identifying effective interventions for the treatment or prevention of communication disorders by supporting welldesigned and wellexecuted clinical trials. This funding opportunity announcement (FOA) supports a cooperative agreement between an NIDCD Project Scientist and an investigator to support a clinical trial that meets ANY of the following criteria: requires FDA oversight, has annual direct costs equal to or greater than $500,000, that is intended to formally establish efficacy, or has a higher risk to potentially cause physical or psychological harm. These investigator-initiated clinical trials are perceived to benefit from close interaction, oversight, and guidance resulting from a cooperative agreement. Only one clinical trial may be proposed in each NIDCD Clinical Trials in Communication Disorders U01 application. Low risk clinical trials not meeting any of the criteria above are referred to the companion NIDCD Clinical Trials in Communication Disorders (R01-Clinical Trial Required) PA-18-334

This team will be responsible for analysis of cytometry based assays for all phases of clinical studies and trials at BMS....
From Bristol-Myers Squibb - Sun, 12 Nov 2017 09:00:42 GMT - View all Pennington, NJ jobs

Communicate effectively with central labs, external vendors and BMS labs engaged in sample analysis to ensure consistent execution of biomarker processing,...
From Bristol-Myers Squibb - Sat, 11 Nov 2017 14:04:25 GMT - View all Princeton, NJ jobs

Please include a cover letter stating research interests and experiences, curriculum vitae, and names and contact information of three references....
From City Of Hope - Sat, 11 Nov 2017 00:57:30 GMT - View all United States jobs

Experience with statistical tools for experimental analysis, standard bioinformatics tools, and programing languages such as Matlab, Python, R etc. is desirable...
From GenapSys - Sat, 11 Nov 2017 00:19:27 GMT - View all United States jobs